Hebei Key Laboratory of Myasthenia Gravis, Center of Treatment of Myasthenia Gravis Hebei Province, First Hospital of Shijiazhuang, No. 9 Fangbei Road, Chang'an District, Shijiazhuang, 050011, Hebei Province, China.
J Cardiothorac Surg. 2020 Sep 29;15(1):270. doi: 10.1186/s13019-020-01320-x.
Despite the burgeoning literature describing preoperative and postoperative risks of a myasthenic crisis after thymectomy (MCAT) in patients with myasthenia gravis, substantial differences exist in the risk factors identified by previous studies. We conducted a meta-analysis to assess the reported risk factors and MCAT risk.
We collected relevant studies on the risk factors for MCAT by searching the PubMed, Embase, The Cochrane Library, China Biology Medicine (CBM), WanFang Data, VIP and CNKI databases. The search period ranged from the establishment of the database to November 2019.
Twenty-five of the 458 identified studies were eligible for the meta-analysis. Seven retrospective cohort studies and 18 case-control studies were included, and 14 risk factors for MCAT were extracted. Meta-analyses of the association between MCAT and risk factors related to the patient's preoperative condition included a preoperative history of MC, preoperative bulbar symptoms, IIa + IIb + III + VI, IIb + III + VI, VI + V, dosage of pyridostigmine bromide prior to the operation, a preoperative AchR-Ab level > 100 (nm/L), preoperative pulmonary function, preoperative complications, and preoperative disease course. Meta-analyses of the association between MCAT and surgery-related risk factors included intraoperative blood loss > 1000 mL and the mode of operation. Meta-analyses of the association between MCAT and postoperative risk factors included postoperative lung infection, thymoma and the WHO classification. The operation time was not an independent risk factor for MCAT.
The independent risk factors for MCAT were a preoperative history of MC, preoperative bulbar symptoms, preoperative MG Osserman stage, preoperative dosage of pyridostigmine bromide, preoperative serum AchR-Ab level, lung function, major postoperative complications, disease duration before thymectomy, blood loss, thoracotomy, postoperative lung infection, thymoma, and WHO classification.
尽管有大量文献描述了重症肌无力患者胸腺切除术后肌无力危象(MCAT)的术前和术后风险,但之前的研究确定的风险因素存在很大差异。我们进行了一项荟萃分析,以评估报告的风险因素和 MCAT 风险。
我们通过检索 PubMed、Embase、The Cochrane Library、中国生物医学文献数据库(CBM)、万方数据、维普和中国知网(CNKI)数据库,收集了关于 MCAT 风险因素的相关研究。检索时间范围从数据库建立到 2019 年 11 月。
在 458 项确定的研究中,有 25 项符合荟萃分析的条件。纳入了 7 项回顾性队列研究和 18 项病例对照研究,提取了 14 个 MCAT 风险因素。对 MCAT 与患者术前状况相关的风险因素之间的关联进行了荟萃分析,包括术前肌无力危象史、术前球部症状、IIa+IIb+III+VI、IIb+III+VI、VI+V、术前使用溴吡斯的明剂量、术前乙酰胆碱受体抗体水平>100(nm/L)、术前肺功能、术前并发症和术前病程。对 MCAT 与手术相关的风险因素之间的关联进行了荟萃分析,包括术中出血量>1000ml 和手术方式。对 MCAT 与术后风险因素之间的关联进行了荟萃分析,包括术后肺部感染、胸腺瘤和 WHO 分类。手术时间不是 MCAT 的独立危险因素。
MCAT 的独立危险因素包括术前肌无力危象史、术前球部症状、术前重症肌无力 Osserman 分期、术前溴吡斯的明剂量、术前血清乙酰胆碱受体抗体水平、肺功能、主要术后并发症、胸腺切除术前病程、出血量、开胸手术、术后肺部感染、胸腺瘤和 WHO 分类。